Enable and Impart Late Stage NCE or "Marketed Compounds"

  • Check with publisher
  • Published date: May 23, 2019
    • Shirley, New York, United States

Recently, generic drugs account for a growing proportion of the global small molecule drug market, and the biosimilars are supposed to gain more achievements in the biopharmaceutical field. More importantly, there are increasing amount of active generic/biosimilar companies are focusing their attention on the development of generics parallel to innovative companies. Therefore, this is critical for many pharmaceutical companies seeking to maximize the value of their products by optimizing the life cycle management (LCM) of branded drugs.

BOC Sciences has extensive experiences in cooperation with many bio/pharmaceutical companies to promote products to market quicker and reduce the development costs. We are professional in both the commercialization of innovative pharmaceuticals and life cycle management strategies. Additionally, our experts not only focus on the time period from release to patent expiration, but also participate in your project plan throughout the lifecycle from discovery to retirement.


Result 0 votes
Alex Brown
0 votes

Useful information

  • Avoid scams by acting locally or paying with PayPal
  • Never pay with Western Union, Moneygram or other anonymous payment services
  • Don't buy or sell outside of your country. Don't accept cashier cheques from outside your country
  • This site is never involved in any transaction, and does not handle payments, shipping, guarantee transactions, provide escrow services, or offer "buyer protection" or "seller certification"

Related listings

  • Lifecycle Management

    Lifecycle Management

    Drug Development Shirley (New York) May 23, 2019 Check with publisher

    As unique products, pharmaceutical products are composed by three different life periods: early development period, highly competitive mid-life period and the significant late post-patent period. Pharmaceutical lifecycle management (LCM) represents t...

  • Late Stage Formulation Development

    Late Stage Formulation Development

    Drug Development Shirley (New York) May 23, 2019 Check with publisher

    The availability of high quality formulations that are designed to achieve therapeutically-relevant pharmacokinetic drug profiles has a pivotal role in determination of the safety and clinical efficacy of medicines. The pharmacists and pharmaceutical...

  • Early Stage Formulation Development

    Early Stage Formulation Development

    Drug Development Shirley (New York) May 23, 2019 Check with publisher

    In the dog-eat-dog market, especially in the pharmaceutical industry, more and more corporations are facing with the ongoing challenge of how to allocate research and development (R&D) resources to make the process work in the most time-efficient...